metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of ...
Journal Information
Vol. 154. Issue 6.
Pages 207-213 (March 2020)
Share
Share
Download PDF
More article options
Visits
4
Vol. 154. Issue 6.
Pages 207-213 (March 2020)
Original article
Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosis
Validación de la versión española del cuestionario Síntomas y Calidad de Vida en los Miomas Uterinos en mujeres con miomatosis uterina
Visits
4
Joaquim Calafa,
Corresponding author
JCalaf@santpau.cat

Corresponding author.
, Santiago Palaciosb, Ignacio Cristóbalc, María Luisa Cañeted, Javier Monleóne, Jorge Fernándezf, Alicia Hernándezg, Francisco Vázquezh
a Hospital de la Santa Creu i Sant Pau-Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain
b Instituto Palacios de Salud de la Mujer, Madrid, Spain
c Universidad Francisco de Vitoria, Madrid, Spain
d Hospital Quiron Salud Toledo, Spain
e Unidad de Patología Uterina, Hospital Universitario La Fe de Valencia. Spain
f Hospital Virgen de las Nieves de Granada, Spain
g Servicio de Ginecología y Obstetricia, Hospital Universitario La Paz, Madrid, Spain
h Clínica Ginecológica CEOGA Lugo, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (3)
Table 1. Sample characteristics.
Table 2. Internal consistency.
Table 3. Discriminant validity.
Show moreShow less
Additional material (1)
Abstract
Aim

To validate the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL)questionnaire in women with uterine myomatosis, in order to assess severity of symptoms, and their impact on health-related quality of life.

Materials and methods

The participants were recruited in gynaecology clinics. The UFS-QoL questionnaire comprises 37 items, 8 of which assess severity of symptoms, and the remaining 29 assess health-related quality of life in 6 subscales. Internal consistency, concurrent and discriminant validity, test-retest reliability, and the scale’s sensitivity to change were evaluated.

Results

A total of 619 patients with uterine myomatosis, and 57 women without myomatosis, took part in the study. Cronbach’s alpha was 0.97, and the test-retest reliability was 0.90 for the overall scale. TheUFS-QoL not only discriminated between patients and healthy controls but also between patients with different degrees of uterine myomatosis. The scale responded to changes after treatment with an effect size of 1.2.

Conclusions

The Spanish version of the UFs-QoL questionnaire, used in a sample of the Spanish population, proved a valid and reliable tool to differentiate patients with uterine myomatosis and different grades of symptoms, and to evaluate the impact of the severity of these symptoms on health-related quality of life. In addition, the UFs-QoL proved sensitive to the changes generated by myomatosis treatment.

Keywords:
Validation
Quality of life
Symptoms
Self-assessment
Uterine myomatosis
Resumen
Objetivo

Validar la versión española del Síntomas y Calidad de Vida en los Miomas Uterinos (SCdV-MU ) en mujeres con miomatosis uterina para evaluar la gravedad de los síntomas y su impacto en la calidad de vida relacionada con la salud.

Materiales y métodos

Las participantes fueron reclutadas en consultas de ginecología. El Cuestionario SCdV-MU consta de 37 ítems, 8 de los cuales evalúan la gravedad de los síntomas, mientras que los 29 restantes evalúan la calidad de vida relacionada con la salud (CVRS) en 6 subescalas. Se determinaron la consistencia interna, la validez concurrente y discriminante, la fiabilidad test-retest y la sensibilidad al cambio de la escala.

Resultados

Un total de 619 pacientes con miomatosis uterina y 57 mujeres sin miomatosis participaron en el estudio. El coeficiente alfa de Cronbach fue de 0.97 y la fiabilidad test-retest de 0.90 para la escala global. El Cuestionario SCdV-MU no solo discriminó entre pacientes y controles normales sino también entre pacientes con distintos grados de miomatosis uterina. La escala respondió a los cambios tras el tratamiento, con un tamaño de efecto de 1.2.

Conclusiones

La versión española del Cuestionario SCdV-MU, administrada en una muestra de la población española, ha demostrado ser una herramienta válida y fiable para diferenciar las pacientes con miomatosis uterina con diferentes grados de síntomas y valorar el impacto de la gravedad de estos síntomas en la calidad de vida relacionada con la salud. Además, el UFS-QoL ha demostrado ser sensible a los cambios generados por el tratamiento de la miomatosis.

Palabras clave:
Validación
Calidad de vida
Síntomas
Autoevaluación
Miomatosis uterina

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2021.02.009
No mostrar más